SEC Contract Filing

Filing Date: 2021-06-11

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>tm2119468d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Exhibit 10.3</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS REGISTRATION RIGHTS
AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;), dated as of June 8, 2021, is made and entered into by and among Colombier Acquisition
Corp., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), Colombier Sponsor LLC, a Delaware limited liability company (the &ldquo;<U>Sponsor</U>&rdquo;),
and the undersigned parties listed under Holder on the signature page&nbsp;hereto (each such party, together with the Sponsor and any
person or entity who hereafter becomes a party to this Agreement pursuant to&nbsp;<U>Section&nbsp;5.2</U>&nbsp;of this Agreement, a &ldquo;<U>Holder</U>&rdquo;
and collectively the &ldquo;<U>Holders</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
and the Sponsor have entered into that certain Securities Subscription Agreement, dated as of February 15, 2021 pursuant to which the
Sponsor purchased an aggregate of 4,312,500 shares after giving effect to stock-splits occurring on or prior to the date hereof (the &ldquo;<U>Founder
Shares</U>&rdquo;) of the Company&rsquo;s Class&nbsp;B common stock, par value $0.0001 per share (the &ldquo;<U>Class&nbsp;B Common Stock</U>&rdquo;)
(up to 562,500 of which are subject to forfeiture depending on the extent to which the underwriter&rsquo;s over-allotment option is exercised);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WHEREAS</B>, the Founder
Shares are convertible into shares of the Company&rsquo;s Class&nbsp;A common stock, par value $0.0001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), on the terms and conditions provided in the Company&rsquo;s amended and restated certificate of incorporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WHEREAS</B>, on June 8, 2021,
the Company and the Sponsor entered into that certain Private Placement Warrants Purchase Agreement, pursuant to which the Sponsor agreed
to purchase an aggregate of 5,250,000 warrants (or up to 5,700,000 warrants if the over-allotment option in connection with the Company&rsquo;s
initial public offering is exercised in full) (the &ldquo;<U>Private Placement Warrants</U>&rdquo;), in a private placement occurring
simultaneously with the closing of the Company&rsquo;s initial public offering; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>WHEREAS</B>, the Company
and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration rights
with respect to certain securities of the Company, as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>NOW</B>,&nbsp;<B>THEREFORE</B>,
in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE&nbsp;I</B></FONT><B><BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>.
The terms defined in this&nbsp;<U>Article&nbsp;I</U>&nbsp;shall, for all purposes of this Agreement, have the respective meanings set
forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Adverse Disclosure</U>&rdquo;&nbsp;shall
mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive Officer
or principal financial officer of the Company, after consultation with counsel to the Company, (i)&nbsp;would be required to be made in
any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statemen